Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Northera
Northera
FDA panel recommends Chelsea Therapeutics drug
Reuters
Thu, 02/23/12 - 05:49 pm
FDA
advisory panels
Chelsea Therapeutics
Northera
Chelsea Therapeutics: FDA Panel Live Blog
TheStreet.com
Thu, 02/23/12 - 10:43 am
FDA
advisory panels
Chelsea Therapeutics
Northera
Chelsea Therapeutics Drug Shouldn’t Be Approved, FDA Says
Bloomberg Businessweek
Wed, 02/22/12 - 08:11 am
FDA
Chelsea Therapeutics
Northera
Still Betting On Chelsea's Flagship Drug?
Seeking Alpha
Wed, 02/15/12 - 10:37 am
Chelsea Therapeutics
Northera
FDA Pharma Meetings for February
Motley Fool
Tue, 01/31/12 - 07:58 am
FDA
Amgen
Xgeva
Cell Therapeutics
Pixuvri
Vivus
Qnexa
Chelsea Therapeutics
Northera
Chelsea Therapeutics gets patent protection on hypotension drug
Reuters
Thu, 12/15/11 - 09:46 am
Chelsea Therapeutics
hypotension
Northera
neurogenic orthostatic hypotension
Parkinson's Disease
9 Biotech Companies With FDA Approval Decision Dates In Q1 2012
Seeking Alpha
Mon, 12/12/11 - 11:14 am
FDA
Fentanyl SL
INSYS Therapeutics
Dapagliflozin
Bristol-Myers Squibb
Prochieve
Columbia Laboratories
Discovery Labs
Surfaxin
NeurogesX
Qutenza
Curis
Roche
vismodegib
Chelsea Therapeutics
Northera
ONYX Pharmaceuticals
Carfilzomib
22 Hot Drugs Facing FDA Approval in 2012
TheStreet.com
Tue, 11/29/11 - 09:09 am
Amarin
AMR101
Ironwood
linaclotide
Merck
Ariad
ridaforolimus
Vivus
Qnexa
Avanafil
Amgen
Xgeva
Cell Therapeutics
pixantrone
Kalydeco
Vertex
ONYX Pharmaceuticals
Carfilzomib
Pfizer
Bristol-Myers Squibb
Eliquis
Chelsea Therapeutics
Northera
Levadex
MAP Pharmaceuticals
Roche
Curis
vismodegib
Biogen Idec
Elan
Tysabri
Amylin
Bydureon
Dapagliflozin
Uplypso
Protalix BioTherapeutics
Teva Pharmaceuticals
BioSante
Bio-T-Gel
Corlux
Corcept Therapeutics
Discovery Labs
Surfaxin
FDA grants priority review to Chelsea's hypotension drug
Reuters
Thu, 11/17/11 - 09:01 am
FDA
Chelsea Therapeutics
hypotension
Northera
Chelsea Therapeutics asks FDA to approve Northera
Yahoo/AP
Wed, 09/28/11 - 12:34 pm
FDA
Northera
Chelsea Therapeutics
Parkinson's Disease
Biotech Clinical Trials Update: CRIS, ALKS, CHTP
Seeking Alpha
Wed, 06/22/11 - 08:14 am
clinical trials
ALKS 5461
depression
Alkermes
Northera
Chelsea Therapeutics
Multimeric-001
flu vaccine
Chelsea Therapeutics International to ask for FDA approval of Northera in the 3rd-quarter
Yahoo/AP
Mon, 04/18/11 - 04:55 pm
Chelsea Therapeutics
FDA
Northera
neurogenic orthostatic hypotension
Chelsea Therapeutics Shares Fly on Hypotension Drug Trials Promise
Seeking Alpha
Tue, 09/21/10 - 12:02 pm
hypotension
Chelsea Therapeutics
Northera
Chelsea rallies on data; drug-sector indexes rise
Marketwatch
Mon, 09/20/10 - 12:37 pm
Chelsea Therapeutics
drug stocks
Northera
Pages
« first
‹ previous
1
2